Scarica l'app Stockscreener
2.00
1.52%
0.03
Precedente Chiudi:
$1.97
Aprire:
$1.96
Volume 24 ore:
75,353
Relative Volume:
0.65
Capitalizzazione di mercato:
$90.90M
Reddito:
$134.00K
Utile/perdita netta:
$-9.93M
Rapporto P/E:
-5.8824
EPS:
-0.34
Flusso di cassa netto:
$-6.72M
1 W Prestazione:
+9.89%
1M Prestazione:
+6.38%
6M Prestazione:
-17.70%
1 anno Prestazione:
+27.06%
Intervallo 1D:
$1.96
$2.03
Intervallo di 1 settimana:
$1.80
$2.03
Portata 52W:
$1.5006
$2.79
Entera Bio Ltd Stock (ENTX) Company Profile
Nome
Entera Bio Ltd
Settore
Industria
Telefono
972-2-532-7151
Indirizzo
KIRYAT HADASSAH, MINRAV BUILDING, JERUSALEM
Confronta ENTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ENTX
Entera Bio Ltd
|
2.00 | 89.96M | 134.00K | -9.93M | -6.72M | -0.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Entera Bio Ltd Stock (ENTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-03-22 | Iniziato | Aegis Capital | Buy |
Entera Bio Ltd Borsa (ENTX) Ultime notizie
Is Entera Bio Ltd. showing signs of accumulation2025 Momentum Check & Reliable Intraday Trade Plans - Newser
Sentiment analysis tools applied to Entera Bio Ltd.July 2025 Catalysts & Growth Focused Entry Point Reports - Newser
Trend analysis for Entera Bio Ltd. this weekQuarterly Profit Review & Weekly Breakout Stock Alerts - Newser
Automated trading signals detected on Entera Bio Ltd.Market Performance Report & Weekly Hot Stock Watchlists - Newser
Entera Bio Ltd. stock momentum explained2025 Trading Volume Trends & Real-Time Volume Surge Alerts - Newser
When is the best time to buy Entera Bio Ltd. stockJobs Report & High Accuracy Trade Alerts - Newser
Using Bollinger Bands to evaluate Entera Bio Ltd.July 2025 Earnings & Weekly Chart Analysis and Guides - Newser
Multi factor analysis applied to Entera Bio Ltd.Weekly Risk Summary & Free Accurate Trade Setup Notifications - Newser
Is Entera Bio Ltd. meeting your algorithmic filter criteriaMarket Sentiment Review & Comprehensive Market Scan Reports - Newser
What candlestick patterns are forming on Entera Bio Ltd.CEO Change & Growth Oriented Trading Recommendations - Newser
Will Entera Bio Ltd. rebound enough to break even2025 Market Overview & Safe Entry Point Identification - Newser
Is a relief rally coming for Entera Bio Ltd. holdersTrend Reversal & Trade Opportunity Analysis - Newser
What MACD signals say about Entera Bio Ltd.Quarterly Earnings Summary & High Yield Stock Recommendations - Newser
What is HC Wainwright’s Forecast for Entera Bio Q3 Earnings? - Defense World
Is it time to cut losses on Entera Bio Ltd.Insider Selling & Verified Entry Point Signals - Newser
Why Entera Bio Ltd. stock attracts strong analyst attentionSell Signal & Community Consensus Trade Alerts - Newser
Entera Bio Ltd. Stocks Attracting Dip BuyersEarnings Overview Report & Real-Time Market Sentiment Reports - newsyoung.net
Q1 Earnings Forecast for Entera Bio Issued By HC Wainwright - Defense World
What the charts say about Entera Bio Ltd. todayPortfolio Performance Report & High Return Trade Guides - Newser
Entera Bio (NASDAQ:ENTX) Upgraded at HC Wainwright - Defense World
Entera Bio Reports Q2 2025 Financial Results and Strategic Progress - MSN
Is Entera Bio Ltd. a defensive stockFree AI Stock Prediction Tool - thegnnews.com
Is Entera Bio Ltd. stock reversal real or fakeTreasury Yields & Daily Profit Focused Screening - Newser
OPKO Health’s (OPK) Oral GLP-2 Analog Selected for a Poster Presentation in Collaboration with Entera Bio (ENTX) - MSN
Statistical indicators supporting Entera Bio Ltd.’s strengthEarly Entry Ideas with Momentum Potential - Newser
Ranking Entera Bio Ltd. among high performing stocks via toolsFree Weekly Top Gainers Forecast Watchlist - Newser
How moving averages guide Entera Bio Ltd. tradingFree Wealth Building Stock Market Ideas - Newser
What makes Entera Bio Ltd. stock price move sharplyCapital Protection Strategy With Risk Analysis - Newser
How Entera Bio Ltd. stock performs during market volatilityWeekly Stock Picks with Trend Confidence - Newser
Entera Bio Second Quarter 2025 Earnings: US$0.057 loss per share (vs US$0.058 loss in 2Q 2024) - Yahoo Finance
Entera Bio Ltd Azioni (ENTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.41%
0.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):